Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market
Investing.com· 4 days agoVerona Pharma (NASDAQ: VRNA ) has announced its first quarter 2024 financial results, highlighting...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 3 days agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 4 days agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Yupelri Dosage: Form, Strength, How To Use, and More
Healthline· 6 days agoYupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet ...
Pulmonary Function Test
Health via Yahoo News· 4 days agoHealthcare providers use PFTs to: Diagnose lung conditions, such as COPD, asthma, emphysema (a form of COPD characterized by damage to the lungs' air...
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
GuruFocus.com via Yahoo Finance· 3 days agoThis product is poised to be the first new inhaled treatment mechanism for Chronic Obstructive Pulmonary Disease (COPD) in over two decades, pending approval ...
Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
FOX 4 Kansas City· 3 days ago$16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results in the wind down of the ...
Varenicline Leads in Helping Smokers Kick the Habit, Study
Medscape· 4 days agoMost smokers do successfully quit after their first attempt. Switching patients from nicotine...
What You Need to Know About Inhalants for Crohn's Disease
Healthline· 4 days agoInhaled corticosteroids aren’t a common treatment option for Crohn’s disease. Crohn’s disease (CD)...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...